Introduction {#S0001}
============

Inflammatory arthritis (IA) is a broad clinical term that covers various rheumatic diseases and represents one of the most common causes of disability among the general population.[@CIT0001],[@CIT0002] The damage caused to joints by IA can lead to a loss of function that creates difficulties for those affected in terms of their ability to care for themselves and to work. Early diagnosis and therapeutic management of IA is therefore crucial for minimizing the progression of joint damage and improving outcomes.[@CIT0003],[@CIT0004]

Rheumatic diseases often affect multiple organs and there is often a lack of any clear sign or symptom that provides a physician with an indication of the specific nature of the condition. This uncertainty can lead to patients experiencing a delay in receiving a diagnosis and treatment, which increases their risk of permanent joint damage and disability.[@CIT0003],[@CIT0004] Indeed, a study of Saudi patients with rheumatoid arthritis (RA) showed that the period between symptom onset and diagnosis can be as long as 30 months,[@CIT0005] while a separate study showed that the majority (55%) of Saudi patients with RA experience a \>50% decrease in their work capacity.[@CIT0006] The prevalence of RA in Saudi Arabia has been reported to be approximately 2.2 cases per 1000 individuals.[@CIT0007] It is unclear whether this disparity represents a true difference in susceptibility within these national populations or a consequence of differences in diagnostic criteria, or a combination of both these factors. Nonetheless, musculoskeletal (MSK) disorders overall represent the second most frequent cause of outpatient visits to primary health centers (PHCs) and private clinics in Saudi Arabia.[@CIT0008] In addition, research from various regions around the world suggests that the level of expertise in applying MSK examination techniques by non-rheumatologists is inconsistent.[@CIT0009]--[@CIT0014]

The most common scenario in which an individual with potential IA interacts with the Saudi health care system is when they first visit a primary care physician (PCP) and describe experiencing joint pain. According to local procedures, the PCP will then likely apply a set of referral criteria in order to identify cases appropriate for a consultation with a rheumatologist. Despite the growing dependence upon advanced radiologic techniques for the diagnosis of rheumatic diseases,[@CIT0015] their lack of availability in PHCs makes it important for PCPs to be confident and knowledgeable regarding MSK examinations for suspected IA. We have recently published a set of referral criteria (the New Early Arthritis Referral Criteria) that are intended to improve the detection of early IA via MSK examination.[@CIT0016],[@CIT0017] The aim of the present study, which used the same cohort of patients enrolled in the new referral criteria study,[@CIT0016],[@CIT0017] was to evaluate the agreement between rheumatologists and PCPs trained by rheumatologists in detecting IA when applying the standardized MSK examination techniques used in the New Early Arthritis Referral Criteria in a real-world setting in Saudi Arabia.

Methods {#S0002}
=======

Study Design {#S0002-S2001}
------------

This quasi-experimental study was conducted in 4 of the 39 PHCs located in Jeddah, Saudi Arabia, with a single PHC from each of Jeddah's 4 main regions selected randomly from those within each. Prior to the study's commencement, the protocol was approved by the institutional review boards at each of the participating PHCs, as well as by the Directorate of Health Affairs at the Saudi Ministry of Health. This study has been conducted in accordance to the Declaration of Helsinki. A total of 30 PCPs and 3 rheumatologists participated in the study. All 30 PCPs received the same training at the same time from the 3 rheumatologists, via a standardized process that ensured they were capable of correctly applying the MSK examinations of the hands and wrists described in the New Early Arthritis Referral Criteria. Detailed definitions and descriptions of these MSK examination techniques have been described previously.[@CIT0016]

Patients {#S0002-S2002}
--------

Any patient who visited a PHC clinic at one of the 4 participating PHCs (Al-Safa, Al-Hamra, Ghulail, or Al-Bawadi) was eligible to be included in the study if they were \>18 years of age, presented with pain in the small joints that had persisted for \>6 weeks, and provided written informed consent. Patients were excluded if they had already been diagnosed with osteoarthritis, fractures of the hands, or a rheumatic disease associated with IA. Each patient who met the eligibility criteria was examined separately by a PCP and then by a rheumatologist, with the findings from each examination recorded and subsequently compared via statistical analysis. The final diagnosis that each patient received was based on the findings of the rheumatologist and the results from subsequent ultrasound and laboratory tests.

Statistical Analysis {#S0002-S2003}
--------------------

As described previously,[@CIT0017] the overall sample size calculated to be appropriate for the cross-sectional study that served as the basis for the current analysis was 203 patients. Kappa statistics with 95% confidence intervals and Fisher's exact tests were used to evaluate the extent of agreement between the MSK examination findings reported by the PCPs and the rheumatologists, with the findings of the rheumatologists' examinations, laboratory findings included, considered as the gold standard. The extent of agreement as indicated by kappa values was defined, according to Cohen's criteria, as follows: none to slight (kappa \<0.20), fair (kappa 0.21--0.40), moderate (kappa 0.41--0.60), substantial (kappa 0.61--0.80), and almost perfect (kappa 0.81--1.00).[@CIT0018] The statistical software we used was SPSS (Version 23).

Results {#S0003}
=======

Patient Demographics {#S0003-S2001}
--------------------

A total of 203 participants were enrolled, with data from 202 patients included in the present analysis and data from 1 patient excluded due to incompleteness. This cohort has been described previously ([Table 1](#T0001){ref-type="table"}).[@CIT0017]Table 1Patient-Reported Clinical And Demographic VariablesNDisease Status*p*-ValueYesNo**Sex**Male3724130.50Female16510461**Age**\<40 years7452220.08≥40 years1287652**Loss of appetite^a^**Yes312560.04No17110368**Stiffness^a^**Yes9351420.02No1097732**Family history of uveitis**Yes7160.01No19512768[^1]

Application Of The Standardized MSK Examination Techniques Used In The New Early Arthritis Referral Criteria By PCPs Following Training By Rheumatologists {#S0003-S2002}
----------------------------------------------------------------------------------------------------------------------------------------------------------

### Joint Swelling {#S0003-S2002-S3001}

Comparison of the examination findings obtained by the PCPs and rheumatologists showed that kappa values for the extent of agreement with regards to assessing swelling of the metacarpophalangeal (MCP) and proximal interphalangeal joints (PIP) and wrist of the right side ranged from 0.14 to 0.41, indicating a slight-to-moderate extent of agreement, with the majority of kappa values in the slight-to-fair range ([Table 2](#T0002){ref-type="table"}). P values were significant for all (p\<0.01 for all except MCP 4, for which p=0.04), which indicates that the extent of agreement observed was highly unlikely to be due to chance. The extent of agreement with regard to swelling of the MCP and PIP joints of the left side was in the slight-to-fair range of kappa values (0.04 to 0.37), while agreement in regard to swelling of the left wrist was moderate (kappa value: 0.41). P values were significant (p\<0.01 for all) for all comparisons except the MCP 4 and MCP 5 joints.Table 2Agreement Between PCPs And Rheumatologists In The Detection Of Joint SwellingJointsPositive FindingnNegative FindingnKappa Value (95% CI)P value**Right hand**MCP 1True8True1720.35 (0.14 to 0.56)\<0.001False14False8MCP 2True8True1560.18 (0.01 to 0.36)0.008False18False20MCP 3True14True1560.36 (0.19 to 0.54)\<0.001False15False17MCP 4True2True1830.14 (−0.09 to 0.37)0.040False7False10MCP 5True2True1900.24 (−0.07 to 0.55)\<0.001False5False5PIP 1True7True1780.41 (0.18 to 0.64)\<0.001False11False5PIP 2True11True1510.23 (0.06 to 0.40)0.001False18False22PIP 3True11True1440.18 (0.02 to 0.34)0.009False23False23PIP 4True6True1670.22 (0.02 to 0.43)0.001False13False14PIP 5True4True1790.25 (0.01 to 0.49)\<0.001False7False11WristTrue27True1230.35 (0.20 to 0.49)\<0.001False15False36**Left hand**MCP 1True7True1650.27 (0.08 to 0.46)\<0.001False19False9MCP 2True7True1630.22 (0.03 to 0.41)0.001False20False11MCP 3True6True1640 18 (−0.00 to 0.36)0.007False20False12MCP 4True1True1810.04 (−0.13 to 0.20)0.606False9False11MCP 5True1True1820.05 (−0.12 to 0.22)0.451False13False6PIP 1True6True1790.37 (0.15 to 0.60)\<0.001False9False8PIP 2True12True1620.37 (0.19 to 0.56)\<0.001False16False12PIP 3True13True1510.29 (0.12 to 0.46)\<0.001False19False19PIP 4True5True1720.21 (0.00 to 0.42)0.002False11False14PIP 5True5True1790.33 (0.08 to 0.57)\<0.001False7False9WristTrue79True640.42 (0.29 to 0.54)\<0.001False35False23[^2]

### Joint Tenderness {#S0003-S2002-S3002}

Similar to the results obtained from evaluations of joint swelling, comparisons of the examination findings obtained by the PCPs and rheumatologists when assessing joint tenderness in the MCP and PIP joints gave kappa values that ranged from 0.22 to 0.39 for the right side, indicating a fair extent of agreement, with a moderate extent of agreement for the right wrist (kappa value: 0.47). P values were highly significant for all (p\<0.001 for all; [Table 3](#T0003){ref-type="table"}). Similarly, fair-to-moderate extent of agreement was observed in comparisons of joint tenderness on the left side, with kappa values ranging from 0.24 to 0.45 and p values being highly significant for all (p\<0.001 for all).Table 3Agreement Between PCPs And Rheumatologists In The Detection Of Joint TendernessJointsPositive FindingnNegative FindingnKappa Value\
(95% CI)P value**Right side**MCP 1True25True1300.36 (0.22 to 0.51)\<0.001False32False15MCP 2True38True1060.36 (0.23 to 0.49)\<0.001False41False17MCP 3True37True1100.39 (0.26 to 0.52)\<0.001False40False14MCP 4True27True1180.31 (0.17 to 0.44)\<0.001False43False14MCP 5True26True1260.37 (0.24 to 0.51)\<0.001False40False8PIP 1True18True1260.22 (0.08 to 0.36)\<0.001False45False13PIP 2True47True850.29 (0.16 to 0.42)\<0.001False49False21PIP 3True47True810.27 (0.14 to 0.40)\<0.001False50False22PIP 4True38True960.29 (0.16 to 0.42)\<0.001False50False17PIP 5True31True1040.26 (0.13 to 0.39)\<0.001False52False15WristTrue33True1260.47 (0.34 to 0.60)\<0.001False9False33**Left side**MCP 1True30True1300.45 (0.31 to 0.59)\<0.001False30False12MCP 2True34True1150.38 (0.24 to 0.51)\<0.001False38False15MCP 3True34True1150.39 (0.26 to 0.52)\<0.001False42False11MCP 4True27True1280.40 (0.26 to 0.53)\<0.001False38False8MCP 5True28True1250.40 (0.26 to 0.53)\<0.001False39False8PIP 1True18True1300.26 (0.12 to 0.40)\<0.001False43False11PIP 2True38True890.24 (0.12 to 0.36)\<0.001False58False16PIP 3True46True880.32 (0.20 to 0.45)\<0.001False52False15PIP 4True42True950.32 (0.19 to 0.45)\<0.001False48False17PIP 5True36True970.27 (0.14 to 0.40)\<0.001False52False17WristTrue78True640.41 (0.28 to 0.54)\<0.001False34False25[^3]

Confirmed Diagnoses Of Inflammatory Arthritis {#S0003-S2003}
---------------------------------------------

Overall, there were 128 of the 203 enrolled patients (63.1%) who received a final diagnosis of IA.

Discussion {#S0004}
==========

The present study investigated the extent of agreement between rheumatologists and PCPs trained by rheumatologists in detecting IA when applying the standardized MSK examination techniques used in the New Early Arthritis Referral Criteria to suspected cases of IA in a real-world setting in Saudi Arabia. Overall, agreement between PCPs and rheumatologists was fair and in some cases moderate. We believe that these promising findings may be built upon by further refining the standardized training process so that, ultimately, the PCPs are capable of identifying early IA with an accuracy similar to that of a rheumatologist. Providing PCPs with the requisite level of training needed to identify IA via MSK examination early and with confidence is expected to improve outcomes for patients, in terms of earlier diagnosis and treatment to minimize disease progression and improve quality of life. Additional positive outcomes for society in general would include reducing the impact of the disease on family and friends and limiting the costs associated with advanced disease and lost workplace productivity.

The promising results demonstrated by the PCPs trained during our study should also be considered in light of published accounts of the inconsistent level of expertise in applying MSK examination techniques by non-rheumatologists in various geographic regions. Indeed, Zaini and colleagues reported low confidence among internal medicine residents in Saudi Arabia when conducting MSK examinations,[@CIT0014] and a US study reported that 78% of internal medicine residents demonstrated a lack of skills in assessing the MSK system via examination.[@CIT0011] Furthermore, a study of medical students from Harvard University noted their inadequate preparation in MSK medicine, including a lack of clinical confidence and cognitive mastery in the field.[@CIT0010] Similar conclusions have been reached by Coady and colleagues, who identified a lack of agreement on what to teach, a lack of confidence in teaching amongst non-MSK specialties, and poor communication between specialties as barriers to improving the teaching of MSK examination,[@CIT0009] Oswald and colleagues, who noted the relatively limited hours devoted to training of MSK examination skills in Canadian medical schools, which ignores the prevalence of these conditions within the general population,[@CIT0012] and Stansfield and colleagues, who reported an evident lack of clinical skills in diagnosing common pathologies of the knees, shoulders, and back among final-year students.[@CIT0013]

Our study has some limitations. It was conducted at 4 PHCs within the same geographic region of Saudi Arabia (Jeddah) and the training of PCPs was provided by 3 rheumatologists who were involved in the development of the New Early Arthritis Referral Criteria and who have expert knowledge of the techniques involved. Whether the training of PCPs can be as effective when scaled up and implemented by a wider team of rheumatologists is not known. Furthermore, our study excluded patients who had a prior diagnosis of osteoarthritis, hand fractures, and rheumatic diseases associated with IA. Understanding the outcomes of our training process in a population that includes those patients would require additional investigation. Moreover, to demonstrate the effect of training in MSK examination skills, a control group of PCPs who did not undergo training by rheumatologist to identify IA would have reduced bias in agreement. Additional limitations include the fact that variability in skills among PCPs and agreement among rheumatologists could not be determined.

In conclusion, our results demonstrate that the training of PCPs by rheumatologists led to an overall fair extent of agreement in detecting IA between these two groups when applying the New Early Arthritis Referral Criteria to suspected cases of IA in a real-world setting in Saudi Arabia. Given the lack of confidence and technical skills that have been highlighted in published studies investigating the competency of MSK examinations, we believe that the use of standardized MSK examination techniques in a standardized teaching process provided by rheumatologists may be capable of equipping PCPs with the skills they need in order to accurately identify cases of early IA. This would, in turn, be expected to provide benefits to patients and wider society in general by allowing earlier therapeutic intervention that would limit the progression of joint damage and improve quality of life for patients as well as reducing associated health care costs and workplace disability.
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[^1]: **Notes:** All p-values were obtained using one-tailed Fisher's exact test, except for loss of appetite (two-tailed). ^a^Patient-reported.

[^2]: **Abbreviations:** CI, confidence interval; MCP, metacarpophalangeal; PIP, interphalangeal.

[^3]: **Abbreviations:** CI, confidence interval; MCP, metacarpophalangeal; PIP, interphalangeal.
